Vincenzo Cerundolo, MD, PhD

Affiliations: 
Radcliffe Department of Medicine University of Oxford, Oxford, United Kingdom 
Website:
https://www.rdm.ox.ac.uk/people/vincenzo-cerundolo
Google:
"Vincenzo Cerundolo"
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Barnkob MB, Michaels YS, André V, et al. (2024) Publisher Correction: Semaphorin 3A causes immune suppression by inducing cytoskeletal paralysis in tumour-specific CD8 T cells. Nature Communications. 15: 3448
Barnkob MB, Michaels YS, André V, et al. (2024) Semmaphorin 3 A causes immune suppression by inducing cytoskeletal paralysis in tumour-specific CD8 T cells. Nature Communications. 15: 3173
Zou Z, Cheng Q, Zhou J, et al. (2024) ATF4-SLC7A11-GSH axis mediates the acquisition of immunosuppressive properties by activated CD4 T cells in low arginine condition. Cell Reports. 43: 113995
Pankhurst TE, Buick KH, Lange JL, et al. (2023) MAIT cells activate dendritic cells to promote T cell differentiation and induce humoral immunity. Cell Reports. 42: 112310
Kandasamy M, Gileadi U, Rijal P, et al. (2023) Recombinant single-cycle influenza virus with exchangeable pseudotypes allows repeated immunization to augment anti-tumour immunity with immune checkpoint inhibitors. Elife. 12
Shenderov E, Kandasamy M, Gileadi U, et al. (2021) Generation and characterization of HLA-A2 transgenic mice expressing the human TCR 1G4 specific for the HLA-A2 restricted NY-ESO-1 tumor-specific peptide. Journal For Immunotherapy of Cancer. 9
Crump NT, Hadjinicolaou AV, Xia M, et al. (2021) Chromatin accessibility governs the differential response of cancer and T cells to arginine starvation. Cell Reports. 35: 109101
Yang H, Rei M, Brackenridge S, et al. (2021) HLA-E-restricted, Gag-specific CD8 T cells can suppress HIV-1 infection, offering vaccine opportunities. Science Immunology. 6
Dölen Y, Gileadi U, Chen JL, et al. (2021) PLGA Nanoparticles Co-encapsulating NY-ESO-1 Peptides and IMM60 Induce Robust CD8 and CD4 T Cell and B Cell Responses. Frontiers in Immunology. 12: 641703
Dölen Y, Valente M, Tagit O, et al. (2020) Nanovaccine administration route is critical to obtain pertinent iNKt cell help for robust anti-tumor T and B cell responses. Oncoimmunology. 9: 1738813
See more...